Jane Mitchell
From Wikipedia, the free encyclopedia
Jane Mitchell is a professor of pharmacology in clinical care medicine at Imperial College London.[1] Her research focusses on the regulation of cardiovascular health and disease, with a particular interest in endothelial cells, prostacyclin (a platelet activator and vasodilator), and nitric oxide.[2]
She finished her PhD with Nobel Laureate John Vane and worked as a postdoctoral fellow with another Nobel Laureate: Ferid Murad. She became a professor when she was 38.[2] Mitchell won the Novartis Prize for Pharmacology in 1999 for her work on cyclooxygeanse biology.[1] In 2012, she won the AstraZeneca Prize for Women in Pharmacology.[3]
Mitchell grew up in a coal mining town. People around her frequently died young from cardiovascular and respiratory diseases, which inspired her to pursue a career in clinical research, with a focus on hearts and lungs.[2] She studied biological sciences at Lancaster University.[2]
